{
    "title": "AstraZeneca eyes 3-drug inhaler opportunity after trial results",
    "url": "https://www.dailymail.co.uk/wires/reuters/article-8456633/AstraZeneca-eyes-3-drug-inhaler-opportunity-trial-results.html",
    "date": "2020-06-24",
    "keywords": [
        "copd",
        "breztri",
        "drug",
        "year",
        "burger",
        "respiratory",
        "death",
        "therapy",
        "risk",
        "approval",
        "pangalos",
        "molecule",
        "june",
        "growth",
        "business",
        "inhaler",
        "wednesday",
        "trial",
        "pt010",
        "disease",
        "success",
        "recurrence",
        "twodrug",
        "company",
        "worsening",
        "condition",
        "air",
        "pollution",
        "chemical",
        "goahead",
        "japan",
        "china",
        "food",
        "administration",
        "astra",
        "fda",
        "half",
        "executive",
        "team",
        "member",
        "mene",
        "triple",
        "trimbow",
        "chiesi",
        "italy",
        "competitor",
        "market",
        "plenty",
        "room",
        "class",
        "blockbuster",
        "industry",
        "term",
        "oncology",
        "surge"
    ],
    "category": [
        "wires",
        "reuters"
    ]
}